openPR Logo
Press release

Rare Neurodegenerative Disease Treatment Market Growth, Share, Trends and Overview 2023-2029

01-25-2023 06:37 PM CET | Health & Medicine

Press release from: Orion Market Research

Rare Neurodegenerative Disease Treatment Market Growth,

The global rare neurodegenerative disease treatment market is anticipated to grow at a considerable CAGR of 68% during the forecast period. All the market players of drug manufacturing company are involved in strategic alliances like acquisitions, partnership and collaboration along with research and development to launch new products to hold their position in the global market. Recently, EPSEN Pharma and Exicure Inc. have signed an exclusive agreement to research, develop and commercialize Spherical Nucleic acid as potential investigation treatment for neurodegenerative disease. Similarly, Biogen had made a strategic partnership with F. Hoffmann - La Roche Ltd. in 2019, to ensure robust distribution of drugs and launched two new drugs named Madopar and Ocruves.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/rare-neurodegenerative-disease-treatment-market

Moreover, Aduhelm had received FDA approval to treat patient with Neurodegenerative disease in August 2021. This drug also helps to cure Alzheimer's disease. Recently, in June 2021, the FDA approved Biogen's Alzheimer's disease drug aducanumab. This is the first medication cleared by US regulators and first Alzheimer's disease treatment drug.

Market Coverage

• The market number available for - 2022-2028
• Base year- 2022
• Forecast period- 2022-2028
• Segment Covered-
o By Indications
o By Drug Type
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Allergan plc., Bayer AG, GlaxoSmithKline plc. , Johnson & Johnson Services Inc., Merck & Co. Inc. and others

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Rare Neurodegenerative Disease Treatment Market Report Segment

By Indications

• Parkinson's Disease
• Amyotrophic Lateral Sclerosis
• Alzheimer's Disease
• Multiple Sclerosis
• Spinal Muscular Atrophy (SMA)
• Huntington Disease Other Indications

By Drug Class

• Immunomodulator DrugCholinesterase Inhibitors
• Dopamine Agonists
• N-methyl-D-aspartate Receptor Antagonists
• Others

A full report of Rare Neurodegenerative Disease Treatment Market is available at: https://www.omrglobal.com/industry-reports/rare-neurodegenerative-disease-treatment-market

Rare Neurodegenerative Disease Treatment Market- Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• ACADIA Pharmaceutical Inc.
• Boehringer Ingelheim International GmbH
• Biogen
• F. Hoffmann - La Roche Ltd.
• H. Lundbeck A/S
• Mitsubishi Tanabe Pharma Corp.
• Novartis AG
• Orion Corp.
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• UCB S.A.
• IPSEN Pharma

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Visit More Report at

https://www.asiatimeskorea.com/press-release/%ed%98%88%ec%a0%84-%ec%a0%84%ea%b5%ac%ec%b2%b4-%eb%8b%a8%eb%b0%b1%ec%a7%88-%ec%8b%9c%ec%9e%a5-%ea%b7%9c%eb%aa%a8-%ec%a0%90%ec%9c%a0%ec%9c%a8-%ec%9d%b8%ec%83%81%ec%a0%81%ec%9d%b8-%ec%82%b0%ec%97%85/196782/

https://www.diario-ya.com/regionales/%e7%be%9f%e6%b0%af%e5%96%b9%e8%8d%af%e7%89%a9%e5%b8%82%e5%9c%ba%e5%a2%9e%e9%95%bf%e3%80%81%e5%88%86%e6%9e%90%e6%8a%a5%e5%91%8a%e3%80%81%e5%88%86%e4%ba%ab%e3%80%81%e8%b6%8b%e5%8a%bf%e5%92%8c%e6%a6%82/273583/

https://sportmsr.com/%d8%a7%d9%84%d8%ad%d8%b5%d8%a9-%d8%a7%d9%84%d8%b3%d9%88%d9%82%d9%8a%d8%a9-%d9%84%d8%b5%d9%88%d8%a7%d9%86%d9%8a-%d8%a7%d9%84%d8%ad%d9%82%d9%86-2022-%d8%a7%d9%84%d8%a7%d8%aa%d8%ac%d8%a7%d9%87%d8%a7/

https://revistaeconomiasocial.com/2022/12/22/cuota-de-mercado-de-lamotrigina-2022-tendencias-jugadores-clave-analisis-de-la-industria-y-pronostico-2022-2028/

https://citytoday-hildesheim.de/index.php/2022/12/22/plaque-disclosing-market-report-2022-nach-hauptakteuren-trends-grose-anteil-und-prognose-2022-2028/

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rare Neurodegenerative Disease Treatment Market Growth, Share, Trends and Overview 2023-2029 here

News-ID: 2900248 • Views:

More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033. Infrastructure as Code (IaC) Service Market Overview The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to Understanding the Process
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033. Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,
Property Management Service Market Rising Demand and Growth Forecast Through 2033
Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033. Property Management Service Market Overview The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSilicon Technologies Co., Ltd., ZTE Corporation,
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033. 5G Chipset Market Overview The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT

All 5 Releases


More Releases for Disease

Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research. Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight: Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and